فهرست مطالب

Journal of Vessels and Circulation - Volume:4 Issue: 1, Winter 2023

Journal of Vessels and Circulation
Volume:4 Issue: 1, Winter 2023

  • تاریخ انتشار: 1402/09/29
  • تعداد عناوین: 6
|
  • Mohammad Hossein Arjmandnia, Maryam Yosefi, Shima Rahimi, Mostafa Vahedian, Mohammadreza Sharifi, Sajjad Rezvan*, Sara Afshari, Narges Kalhor, Farbod Eshraghi Pages 1-6
    Background and aim

    This cross-sectional study aimed to investigate the association between congenital heart diseases (CHD) in fetuses with choroid plexus cysts (CPCs) detected through fetal anomaly sonography. The study was conducted at Masoumeh Children Hospital in 2019.

    Materials and Methods

    A total of 250 participants were enrolled using an available sampling method. Data collected included maternal age, gestational age, fetal sex, CPC presence, and CHD diagnosis. Fetal echocardiography was performed, and participants were categorized into groups with and without CHD. Statistical analyses were carried out using SPSS software version 22. Descriptive statistics, chi-square tests, and independent t-tests were employed for data description and comparison.

    Results

    The mean age of mothers with CPCs was 32.1 ± 10.92 years, while in the healthy mothers' group, it was 32.78 ± 10.73. CPCs were observed in 57.8% of female neonates and 62.6% of male neonates, with no significant statistical relationship to fetal sex. Although the group with CPCs exhibited more abnormal fetal echocardiographic findings, no significant association was found between these findings and CPC presence. Additionally, no significant relationship was identified between pregnancy term and CPC presence.

    Conclusion

    Infants with Choroid Plexus Cyst had a higher incidence of congenital heart defects as seen on Echo, but there was no significant correlation between the presence of these cysts and heart defects. Thus, parents need not worry.

    Keywords: Congenital Heart Diseases, Plexus Choroid Cyst, Fetal Anomalies
  • Zahra Movahedi, Hanieh Hajyan, Mostafa Vahedian, Shima Noriani, Mahnaz Mosleh, Amin Mohabatdoust*, Moteza Khoshgoftar Pages 7-14
    Introduction and aim

    It is necessary to evaluate the ability to accurately distinguish cases of pneumonia caused by Covid-19 from other cases of pneumonia in blood parameters. Therefore, the aim of the current study was to evaluate the ability of routine laboratory tests to differentiate pneumonia caused by Covid-19 in suspected and confirmed patients with Covid 19.

    Materials and methods

    in this study, which was done in a cross-sectional analytical way. The information of all patients who tested positive for Covid-19 or were suspected of this disease and who met the criteria for entering the study were recorded. Laboratory findings were compared between definite and suspected cases of covid-19 in children. Finally, the data. Statistical analysis was done using SPSS version 26 software. The significant level for all tests was considered less than 0.05.

    Results

    The average age of the patients was 6.16 ± 3.94 years. 56 children (46.7%) boys and 64 children (53.3%) girls were studied. The amount of WBC (P=0.021), the number of lymphocytes (P=0.000), ESR (P=0.021), CRP (P=0.023), D-dimer (P=0.012), had a statistically significant difference between the two groups. . But the amount of Hb (P=0.413). Platelet (P=0.813), BUN (P=0.299), Cr (P=0.541), Na (P=0.265), K (P=0.973), LDH (P=0.275), AST (P= 0.722), ALT (P=0.699), Alb (P=0.341), PT (P=0.834), PTT (P=0.499), Trop (P=0.121), Ferritin (P=0.233) statistical difference between the two groups No significance was found.

    Conclusion

    The result showed that the inflammatory values of ESR and CRP are high in children who are persistently infected with Covid-19. Leukopenia and lymphopenia are also seen in these patients. These findings in children presenting with the complaint of Covid-19 lead us to the fastest possible diagnosis and early treatment in these patients.

    Keywords: Covid 19. Hematology, indicator
  • Javad Khodadadi*, Amir Hossein Safai Moghadam, Abolfazl Mohammadbeigi, Masoud Ahmadi, Aylar Mohammadi, Hamideh Mirmohammadi Pages 15-22
    Introduction and aim

    In the severe form of Covid 19, the vital organs of the body experience dysfunction such as respiratory distress, which may eventually lead to the death of the patient. The present study was conducted with the aim of investigating the effect of Actmera drug on the recovery of patients suffering from the severe form of Covid-19 disease.

    Materials and methods

    The present study was a retrospective cohort study. which was done in Kamkar Hospital in the summer of 2021. The studied data include age, sex, underlying disease, severity of pulmonary involvement, blood oxygen saturation percentage, duration of hospitalization, need for mechanical ventilation, etc. candidate countries to receive Actmera drug, were extracted and compared..

    Results

    70 patients (50%) were male and 70 patients (50%) were female. The average age of the patients was 55.96±14.18. Clinical symptoms, the average number of days dependent on a ventilator, the number of days receiving oxygen with a reserve bag and the number of days receiving nasal, the number of days hospitalized in the normal department, in the special care departments, as well as the OUTCOME of the patients did not have a statistically significant difference between the two groups (P >0.05). Among the laboratory variables of lymph flow, lactate dehydrogenase was not statistically significantly different between the two groups (P>0.05). But the course of CRP level had a statistically significant difference (P<0.05). There was a statistically significant difference in blood oxygen saturation percentage in room air and blood oxygen saturation with auxiliary oxygen between the two groups (P<0.05).

    Conclusion

    The results showed that the drug Actmera was effective in the course of recovery and increasing the amount of blood lymphocytes and blood oxygen of the patients, but it did not have much effect in reducing the need for special care and the outcome of death. For this reason, there is a need for more clinical trials to prove the effectiveness of the drug.

    Keywords: Covid 19, Tocilizumab, ARDS, Intensive care unit
  • Mahta Eskandarnejad, Leila Heidarzadeh, Parisa Mohammadzadeh, Masumeh Zamanlu* Pages 23-28
    Background and Aim

    Autonomic psychophysiology has opened a new field in modern sports science and practice, providing effective means to improve swimming training and skills. Of the famous items of this technology is extremity temperature, which gives an estimate of pleasure and autonomic balance. Nevertheless, the literature on this area and swimming shows a significant gap. This study measures and interprets the extremity temperature of swimmers during swimming training, which can be beneficial for adjusting training approaches and designing neuroscience interventions (including biofeedback) for athletic peak performance.

    Materials and Methods

    A total of 10 teen swimmers voluntarily participated in this research. They were 11 to 13 years old (30% male [n=3]). They were under training by the leading researchers, selected with available sampling, and grouped as fully trained and semi-trained (each group n=5). Informed consent was obtained, and a 15-min recording session of the extremity temperature was performed, during rest along with the challenge of swimming competition imagery. The findings were ultimately compared in the two groups.

    Results

    The semi-trained group had a higher extremity temperature than the fully trained group (29.52±3.19 vs 30.74±4.83), indicating more pleasure and autonomic balance during swimming imagery. Therefore, complete swimming training was associated with relative dominance of sympathetic activity and unpleasant autonomic imbalance.

    Conclusion

    The present study’s findings showed that competitive tensions and involvement in technical details at the end of swimming training might cause unpleasant emotions and physical alterations. Such conditions ought to be adjusted.

    Keywords: Sport physiology, sympathetic nervous system, parasympathetic nervous system, autonomic neurophysiology, well-being, pleasure
  • Mehdi Kargarfard, Mohammad Mahdi Soltani, Mohammad Soltani, Shahla Hojjat, Reihaneh Seyedebrahimi, Shima Ababzadeh, Faezeh Vahidmoghadam* Pages 29-36
    Background

    Cardiac rehabilitation program (CRP) is a non-pharmacological treatment in patient with coronary heart disease (CHD). The present study was aimed the effect of CRP on adiponectin and lipid profiles in CHD patients during 8 weeks.

    Materials and Methods

    Sixty patients with CHD were divided to 2 groups: the exercise group (EG), who completed a series of CRP (3 times a week, in the morning, at 60-85% of MHR, lasted 45-60 minutes for 8 weeks), and a control group (CG) who did not exercise during 8 weeks. In each group, 16 patients were female and 14 patients were male (n = 30). The body mass index (BMI), waist to hip (WHR), cardiorespiratory variables were determined at baseline after 8-week. Medication and diet remained unchanged in both groups during this period. Data were evaluated by independent t-tests by SPSS software in the significant level P-value < 0.05.

    Results

    The results showed that there was a significant difference in anthropometric and cardiorespiratory variables except in RDBP between two groups after CRP. Also, a significant decrease was observed in the EG group for serum TC, LDL and TG levels, RSBP, body weight, BMI, WHR and a significant increase for FC, HDL and adiponectin levels compared to baseline (P < 0.05). HDL-cholesterol level in exercise group was higher than control group after CRP (P < 0.05).

    Conclusion

    Cardiac rehabilitation based on aerobic exercise training may improve plasma lipid profile and adiponectin level in CHD patients, in the absence of changes in diet or medication.

    Keywords: Coronary heart disease, Cardiac rehabilitation program, Adiponectin, Lipid profile
  • Hosein Heydari, Sajjad Rezvan, Meysam Feizollahjani, Zahra Movahedi* Pages 37-44
    Introduction

    Although Kawasaki disease-like syndromes have previously been linked to other viral infections, these patients showed higher levels of pro-inflammatory markers than other cohorts, which may reflect a particularly strong immunological reaction to SARS-CoV-2. This article examines a case of comorbidity between Kawasaki and Covid 19 in a 4-year-old child who complained of fever. 

    Case presentation

    We describe the case of a 4-year-old child admitted and diagnosed with classic Kawasaki disease, who also screened positive for COVID-19 in the setting of fever and minimal respiratory symptoms. The patient was treated per treatment guidelines, with intravenous immunoglobulin and high-dose aspirin, and subsequently defervesced with resolution of her clinical symptoms. with instruction to quarantine at home for 14 days from the date of her positive test results for COVID-19.

    Conclusions

    Consideration of the results of this case report is essential for other pediatric care professionals with COVID-19, as understanding of clinical demonstration patterns continues to evolve. For more information on the clinical course of children with COVID-19, Especially in cases where the disease coincides with Kawasaki, it is necessary.

    Keywords: Covid 19, Kawasaki, child